Cumberland Pharmaceuticals (CPIX) Reports Q4 Loss of $0.14
Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.14). Revenue for the quarter came in at $10.44 million.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
